ZA807293B - Antiallergic and antiulcer 1-oxo-1h-thiazolo(3,2-a)-pyrimidine-2-carboxamides and intermediates therefor - Google Patents

Antiallergic and antiulcer 1-oxo-1h-thiazolo(3,2-a)-pyrimidine-2-carboxamides and intermediates therefor

Info

Publication number
ZA807293B
ZA807293B ZA00807293A ZA807293A ZA807293B ZA 807293 B ZA807293 B ZA 807293B ZA 00807293 A ZA00807293 A ZA 00807293A ZA 807293 A ZA807293 A ZA 807293A ZA 807293 B ZA807293 B ZA 807293B
Authority
ZA
South Africa
Prior art keywords
antiulcer
thiazolo
antiallergic
carboxamides
pyrimidine
Prior art date
Application number
ZA00807293A
Other languages
English (en)
Inventor
S Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA807293B publication Critical patent/ZA807293B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA00807293A 1979-11-23 1980-11-21 Antiallergic and antiulcer 1-oxo-1h-thiazolo(3,2-a)-pyrimidine-2-carboxamides and intermediates therefor ZA807293B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (1)

Publication Number Publication Date
ZA807293B true ZA807293B (en) 1981-12-30

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807293A ZA807293B (en) 1979-11-23 1980-11-21 Antiallergic and antiulcer 1-oxo-1h-thiazolo(3,2-a)-pyrimidine-2-carboxamides and intermediates therefor

Country Status (35)

Country Link
JP (1) JPS5687586A (cs)
KR (1) KR830004322A (cs)
AR (2) AR228859A1 (cs)
AT (1) AT380883B (cs)
AU (1) AU520995B2 (cs)
BE (1) BE886319A (cs)
CA (1) CA1143731A (cs)
CH (1) CH649299A5 (cs)
CS (1) CS241476B2 (cs)
DD (1) DD154608A5 (cs)
DE (2) DE3050491C2 (cs)
DK (1) DK151811C (cs)
EG (1) EG14929A (cs)
ES (1) ES497066A0 (cs)
FI (1) FI67706C (cs)
FR (1) FR2470132A1 (cs)
GB (1) GB2063862B (cs)
GR (1) GR72132B (cs)
GT (1) GT198066458A (cs)
HU (1) HU179091B (cs)
IE (1) IE50404B1 (cs)
IL (1) IL61535A (cs)
IN (1) IN154926B (cs)
IT (1) IT1209373B (cs)
LU (1) LU82950A1 (cs)
NL (1) NL182565C (cs)
NO (1) NO803521L (cs)
NZ (1) NZ195596A (cs)
PH (1) PH16666A (cs)
PL (1) PL132354B1 (cs)
PT (1) PT72090B (cs)
SE (1) SE448732B (cs)
SU (1) SU1042620A3 (cs)
YU (1) YU41953B (cs)
ZA (1) ZA807293B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
LU82950A1 (fr) 1981-06-04
PL132354B1 (en) 1985-02-28
NO803521L (no) 1981-05-25
NL182565C (nl) 1988-04-05
NZ195596A (en) 1984-05-31
FI67706C (fi) 1985-05-10
IL61535A (en) 1984-06-29
GB2063862B (en) 1983-06-22
ES8203363A1 (es) 1982-04-01
PH16666A (en) 1983-12-13
CS241476B2 (en) 1986-03-13
JPS617432B2 (cs) 1986-03-06
SU1042620A3 (ru) 1983-09-15
KR830004322A (ko) 1983-07-09
CH649299A5 (fr) 1985-05-15
AR231296A1 (es) 1984-10-31
PL228008A1 (cs) 1981-12-11
DE3050491C2 (de) 1985-10-10
IN154926B (cs) 1984-12-22
DK151811B (da) 1988-01-04
AT380883B (de) 1986-07-25
IL61535A0 (en) 1980-12-31
SE8008189L (sv) 1981-05-24
DE3043979C2 (de) 1986-08-21
YU41953B (en) 1988-02-29
AU520995B2 (en) 1982-03-11
PT72090A (en) 1980-12-01
GB2063862A (en) 1981-06-10
JPS5687586A (en) 1981-07-16
FI803628L (fi) 1981-05-24
CS782080A2 (en) 1985-06-13
CA1143731A (en) 1983-03-29
DK413180A (da) 1981-05-24
AU6459580A (en) 1981-05-28
GR72132B (cs) 1983-09-19
FI67706B (fi) 1985-01-31
PT72090B (en) 1981-09-29
AR228859A1 (es) 1983-04-29
ATA570780A (de) 1985-12-15
DK151811C (da) 1988-06-06
DE3043979A1 (de) 1981-09-03
SE448732B (sv) 1987-03-16
NL8006362A (nl) 1981-06-16
GT198066458A (es) 1982-05-15
IE802418L (en) 1981-05-23
YU295080A (en) 1983-06-30
DD154608A5 (de) 1982-04-07
NL182565B (nl) 1987-11-02
HU179091B (en) 1982-08-28
IE50404B1 (en) 1986-04-16
ES497066A0 (es) 1982-04-01
IT1209373B (it) 1989-07-16
FR2470132A1 (fr) 1981-05-29
FR2470132B1 (cs) 1983-07-29
EG14929A (en) 1989-01-30
IT8026176A0 (it) 1980-11-21
BE886319A (fr) 1981-05-25

Similar Documents

Publication Publication Date Title
GB2064520B (en) A-aryl-1h-1,2,4-triazole-1-ethanols
DE3069964D1 (en) Chair
JPS55133250A (en) Wheelchair
SG33683G (en) 8-substituted-4-amino-3-quinoline-carboxylic acids and esters-antisecretory,anti-ulcer compounds
JPS5620411A (en) Chair
FI802361A7 (fi) Vaunu raskalle kuormalle
DE3060083D1 (en) Chair
CS528780A2 (en) Zpusob vyroby substituovanych pyrido-(1,2-a)pyrimidinu
NZ193666A (en) 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles
GB2063862B (en) Antiallergic and antiulcer 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carboxamides and intermediates therefor
AU522430B2 (en) Stringer
PT72001A (en) New 1-oxadethiacephalosporin derivatives and the production thereof
CS340780A2 (en) Zpusob vyroby pyrazolo (1,5 c) chinazolinovych derivatu
ZA804183B (en) 1,2,4-thiadiazolyloxyphenylureas
GB2066808B (en) 1-aminopropan-2-ols
JPS55146117A (en) Chair
ZA801526B (en) 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
JPS55149410A (en) Parts fitting structure
JPS55136056A (en) Wheelchair
GB2118169B (en) 1,1,1-trichlorotriacontane
JPS5624213A (en) Parts fitting structure
JPS55149405A (en) Parts fitting structure
GB2055832B (en) 1,3,4-thiadiazol-2-yl-4-hydroxy-1-methyl-2-imidaxolidinones
CA46125S (en) Seating group
CA46215S (en) Seating group